MORGAN STANLEY PLC/CALL/MERCK & CO./170/0.1/20.06.25 Share Price

Warrant

DE000MB8B1M1

Market Closed - Börse Stuttgart 12:07:56 21/05/2024 pm IST
0.181 EUR -9.05% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./170/0.1/20.06.25
Current month-9.95%
1 month-2.45%
Date Price Change
21/24/21 0.181 -9.05%
20/24/20 0.199 +9.94%
17/24/17 0.181 -4.23%
16/24/16 0.189 -3.08%
15/24/15 0.195 +17.47%

Delayed Quote Börse Stuttgart

Last update May 21, 2024 at 12:07 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB8B1M
ISINDE000MB8B1M1
Date issued 04/07/2023
Strike 170 $
Maturity 20/06/2025 (395 Days)
Parity 10 : 1
Emission price 0.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.32
Lowest since issue 0.052
Spread 0.004
Spread %2.12%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131 USD
Average target price
141.6 USD
Spread / Average Target
+8.13%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW